Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Magnetic resonance imaging (MRI) scanners have been used since the 1980s to take detailed images inside the body – helping doctors to make a medical diagnosis and investigate the staging of a disease.
An international team of researchers, led by Dr Munitta Muthana from the University of Sheffield’s Department of Oncology, have now found MRI scanners can non-invasively steer cells, which have been injected with tiny super-paramagnetic iron oxide nanoparticles (SPIOs), to both primary and secondary tumour sites within the body.
This targeted approach is extremely beneficial for patients as it dramatically increases the efficiency of treatment and drug doses could potentially be reduced – helping to alleviate side effects.
Revolutionary cell-based therapies, which exploit modified human cells to treat diseases such as cancer, have advanced greatly over recent years. However, targeted application of cell-based therapy in specific tissues, such as those lying deep in the body where injection is not possible, has remained problematic.
The new research suggests MRI scanners are the key to administering treatments directly to both primary and secondary tumours wherever they are located in the body.
The study, published today (date) in Nature Communications shows that cancer mouse models injected with immune cells carrying SPIOs and armed with the cancer killing oncolytic virus (OV) which infects and kills cancer cells, showed an 800 per cent increase in the effects of the therapy.
Dr Munitta Muthana, from the University of Sheffield, said: “Our results suggest that it is possible to use a standard MRI scanner to naturally deliver cell-based therapies to both primary and secondary tumours which would normally be impossible to reach by injection.
“This not only increases the therapeutic efficacy but also decreases the risk of unwanted side effects.
“The beauty of using the MRI scanner to administer the therapy is that you can also use it for its original purpose providing a real-time image-guide to ensure the treatment has gone where it is needed.”
The Latest on: Tumour busting therapies
via Google News
The Latest on: Tumour busting therapies
- Life after stroke: Questions and answers about stroke rehabilitationon April 30, 2021 at 4:55 am
May is National Stroke Awareness Month, and physiatrist Monica Verduzco-Gutierrez, MD, of The University of Texas Health Science Center at San Antonio answers some questions ...
- Trillium Therapeutics (TSX:TRIL): A Pharma Stock With Huge Upside Potentialon April 29, 2021 at 11:08 am
The clinical-stage immuno-oncology company is developing revolutionary cancer treatment therapies, and it could be an excellent value pick for investors today. I will discuss the company and why its ...
- An experimental gene therapy was little Alissa's only hope. Now, instead of certain death, she faces an uncertain future.on April 25, 2021 at 8:54 am
Before Alissa received the diagnosis of Sandhoff disease, an extremely rare condition, he already had stumbled across the idea of gene therapy. If they could just repair the faulty gene Alissa ...
- Nurses could end the misery of five million Britons suffering from leaky bladders - by injecting them with BOTOXon April 24, 2021 at 3:01 pm
Botox, better known as a wrinkle-busting injection for the face ... the UK's top specialists say this is just one of a host of therapies patients are missing out on, unnecessarily, because ...
- CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030on April 23, 2021 at 2:58 am
New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 ...
- Immunotherapy for Melanomaon April 22, 2021 at 5:00 pm
This "second generation version" of immunotherapy works by increasing the number of cancer-busting T-cells ... with chimeric antigen receptor T-cell therapy, or CAR-T, in treating lymphoma ...
- COVID-19 raises fresh challenges for children with epidermolysis bullosa and their familyon April 22, 2021 at 1:21 pm
Around 500,000 people live with epidermolysis bullosa, a genetic skin condition with no cure Scientists are exploring different treatment options: protein therapy, cell therapy and gene therapy ...
- JP Gabriel watched from the bleachers as the pandemic raged. Now head of supply chain at Ocugen, he's ready to baton April 22, 2021 at 10:38 am
The world was in the middle of the most pressing public health risk his generation had ever seen, and JP Gabriel felt like he was sitting on the sidelines. As a VP of biologics and mRNA manufacturing ...
- Young cancer survivor lives life to the fulleston April 21, 2021 at 5:01 pm
If you were to meet Navi Indran Pillai in person, you probably wouldn’t believe that she is a breast cancer survivor or ... is from the hormonal therapy. She may be 30, but she has already ...
via Bing News